References

Bayry, J. and D.F. Tough, 2005. Is RNA interference feasible for the control of foot-and-mouth disease outbreaks. Trends Immunol., 26: 238-239.
Direct Link  |  

Bennasser, Y., M.L. Yeung and K.T. Jeang, 2007. RNAi Therapy for HIV Infection. Biodrugs, 21: 17-22.
Direct Link  |  

Biswas, S., A. Sanyal, D. Hemadri, C. Tosh, J.K. Mohapatra, R.M. Kumar and S.K. Bandyopadhyay, 2006. Sequence analysis of the non-structural 3A and 3C protein-coding regions of foot-and-mouth disease virus serotype Asia1 field isolates from an endemic country. Vet. Microbiol., 116: 187-193.
Direct Link  |  

Boden, D., O. Pusch, F. Lee, L. Tucker and B. Ramratnam, 2003. Human immunodeficiency virus type 1 escape from RNA interference. J. Virol., 77: 11531-11535.
CrossRef  |  Direct Link  |  

Brown, F., 2003. The history of research in foot-and-mouth disease. Virus Res., 91: 3-7.
Direct Link  |  

Chen, W., W. Yan, Q. Du, L. Fei and M. Liu et al., 2004. RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice. J. Virol., 78: 6900-6907.
CrossRef  |  Direct Link  |  

Chen, X., Q. Feng, Z. Wu, Y. Liu and K. Huang et al., 2003. RNA-dependent RNA polymerase gene sequence from foot-and-mouth disease virus in Hong Kong. Biochem. Biophys. Res. Commun., 308: 899-905.
Direct Link  |  

Cullen, B.R., 2002. RNA interference: Antiviral defence and genetic tool. Nat. Immunol., 3: 597-599.
Direct Link  |  

Das, A.T., T.R. Brummelkamp, E.M. Westerhout, M. Vink, M. Madiredjo, R. Bernards and B. Berkhout, 2004. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol., 78: 2601-2605.
CrossRef  |  Direct Link  |  

Domingo, E. and C. Escarmis, 2003. Evolution of foot-and-mouse disease virus. Virus Res., 91: 47-63.

Elbashir, S.M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber and T. Tuschl, 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411: 494-498.
CrossRef  |  Direct Link  |  

Feng, Q., H. Yu, Y. Liu, C. He and J. Hu et al., 2004. Genome comparison of a novel foot-and-mouth disease virus with other FMDV strains. Biochem. Biophys. Res. Commun., 323: 254-263.
Direct Link  |  

Fire, A., S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver and C.C. Mello, 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391: 806-811.
CrossRef  |  PubMed  |  Direct Link  |  

Henry, S.D., P. Wegen, H.J. Metselaar, H.W. Tilanus, B.J. Scholte and L.W. Laan, 2006. Simultaneous targeting of HCV Replication and viral binding with a single Lentiviral vector Containing Multiple RNA Interference Expression Cassettes. Mol. Ther., 1016: 1-9.
Direct Link  |  

Jacque, J.M., K. Triques and M. Stevenson, 2002. Modulation of HIV-1 replication by RNA interference. Nature, 418: 435-438.
PubMed  |  Direct Link  |  

Jinding, C., Z. Mingqiu, K.H. Hui and F.C. Leung, 2006. Molecular characterization of foot-and-mouth disease virus in Hong Kong during 2001-2002. Virus Genes, 32: 139-143.
CrossRef  |  Direct Link  |  

Joyappa, D.H., S. Sasi, K.C. Ashok, K.C. Ashok, G.R. Reddy and V.V.S. Suryanarayana, 2009. The plasmid constructs producing shRNA corresponding to the conserved 3D polymerase of Foot and Mouth Disease virus protects guinea pigs against challenge virus. Vet. Res. Commun., 33: 263-271.
Direct Link  |  

Kahana, R., L. Kuznetzova, A. Rogel, M. Shemesh, D. Hai, H. Yadin and Y. Stram, 2004. Inhibition of foot-and-mouth disease virus replication by small interfering RNA. J. Gen. Virol., 85: 3213-3217.
Direct Link  |  

Kanda, T., Y. Kusov, O. Yokosuka, V.G. Muller, 2004. Interference of hepatitis A virus replication by small interfering RNAs. Biochem. Biophys. Res. Commun., 318: 341-345.
Direct Link  |  

Karagiannis, T.C. and A. El-Osta, 2005. RNA interference and potential therapeutic application of short interfering RNA. Cancer Gene Ther., 12: 787-795.
Direct Link  |  

Kim, S.M., K.N. Lee, J.Y. Park, Y.J. Ko, Y.S. Joo, H.S. Kim and J.Y. Park, 2008. Therapeutic application of RNA interference against foot-and-mouth in vitro and in vivo. Antiviral Res., 80: 178-184.
Direct Link  |  

Kim, S.M., K.N. Lee, S.J. Lee, Y.J. Ko and H.S. Lee et al., 2010. Multiple shRNAs driven by U6 and CMV promoter enhances efficiency of antiviral effects against foot-and-mouse disease virus. Antiviral Res., 80: 307-317.
Direct Link  |  

Kitabwalla, M. and R.M. Ruprecht, 2002. RNA interference-a new weapon against HIV and beyond. N. Engl. J. Med., 347: 1364-1367.
Direct Link  |  

Konishi, M., C.H. Wu, M. Kaito, K. Hayashi, S. Watanabe, Y. Adachi and G.Y. Wu, 2006. siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations. J. Viral. Hepat., 13: 756-761.
Direct Link  |  

Levy, K., Y.J. Guo, Y.L. Zhang, K.Y. Wang, Y. Zhu and S.H. Sun, 2009. Transient inhibition of foot-and-mouth disease virus replication by siRNAs silencing VP1 protein coding region. Res. Vet. Sci., 86: 443-452.
Direct Link  |  

Liu, M., W. Chen, Z. Ni, W. Yan and L. Fei et al., 2005. Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome. J. Virol., 336: 51-59.
Direct Link  |  

McCaffrey, A.P., H. Nakai, K. Pandey, Z. Huang and F.H. Salazar et al., 2003. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol., 21: 639-644.
Direct Link  |  

Pereira, H.G., 1981. Foot and Mouth Disease. In: Virus Disease of Food Animals, Gibbs, E.P.J., (Ed.). Academic Press Inc., San Diego, pp: 333-363.

Reed, L.J. and H. Muench, 1938. A simple method of estimating fifty percent endpoints. Am. J. Epidemiol., 27: 493-497.
CrossRef  |  Direct Link  |  

Saiz, M., J. Nunez, A. Jimenez-Clavero, E. Baranowski and F. Sobrino, 2002. Foot-and-mouth disease virus: Biology and prospects for disease control. Microb. Infect., 4: 1183-1192.
CrossRef  |  PubMed  |  

Santos, T., Q. Wu, S. Botton and M.J. Grubman, 2005. Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus. Virol., 335: 222-231.
Direct Link  |  

Scherr, M., K. Battmer, B. Schultheis, A. Ganser and M. Eder, 2005. Stable RNA interference (RNAi) as an option for anti-bcr-abl therapy. Gene Ther., 12: 12-21.
Direct Link  |  

Shlomai, A. and Y. Shaul, 2004. RNA interference-small RNAs effectively fight viral hepatitis. Liver Int., 24: 526-531.
Direct Link  |  

Stevenson, M., 2003. Dissecting HIV-1 through RNA interference. Nature, 3: 851-858.
Direct Link  |  

Tuschl, T., 2002. Expanding small RNA interference. Nat. Biotechnol., 20: 446-448.
Direct Link  |  

Wu, H.L., L.R. Huang, C.C. Huang, H.L. Lai and C.J. Liu et al., 2005. RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant. Gastroenterol., 128: 708-716.
Direct Link  |  

Zamore, P.D., 2001. RNA interference: listening to the sound of silence. Nature, 8: 746-750.
Direct Link  |